Vaccine Adjuvant in Immunocompromised Patients | Product Monograph

Home

Contact

Site Map

Vaccine Adjuvant in Immunocompromised Patients

Key Takeaways

•	Zadaxin adds power to hepatitis B and influenza vaccines.
•	The exemplary safety profile of Zadaxin allows for use in renally compromised and elderly patients.
•	Zadaxin provides more than 6 times the typical response to revaccination in previous nonresponders.
•	Zadaxin has shown the greatest effect in patients older than 80 years and has been used safely in patients as old as 101 years.